These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Adiponectin in chronic kidney disease has an opposite impact on protein-energy wasting and cardiovascular risk: two sides of the same coin. Park SH; Carrero JJ; Lindholm B; Stenvinkel P Clin Nephrol; 2009 Aug; 72(2):87-96. PubMed ID: 19640365 [TBL] [Abstract][Full Text] [Related]
7. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease. Hyun YY; Lee KB; Oh KH; Ahn C; Park SK; Chae DW; Yoo TH; Cho KH; Kim YS; Hwang YH; Nutrition; 2017 Jan; 33():254-260. PubMed ID: 27692989 [TBL] [Abstract][Full Text] [Related]
11. Adiponectin and cardiovascular outcomes among hemodialysis patients. Abdallah E; Waked E; Nabil M; El-Bendary O Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012 [TBL] [Abstract][Full Text] [Related]
12. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients. Markaki A; Kyriazis J; Stylianou K; Fragkiadakis GA; Perakis K; Margioris AN; Ganotakis ES; Daphnis E PLoS One; 2012; 7(12):e52350. PubMed ID: 23285003 [TBL] [Abstract][Full Text] [Related]